New Zealand markets open in 5 hours 55 minutes

NeuroMetrix, Inc. (NURO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7200+0.1800 (+3.96%)
As of 09:57AM EST. Market open.

NeuroMetrix, Inc.

4B Gill Street
Woburn, MA 01801
United States
781 890 9989

IndustryMedical Instruments & Supplies
Full-time employees20

Key executives

NameTitlePayExercisedYear born
Dr. Shai N. GozaniFounder, Chairman, CEO, Pres & Sec.35.78kN/A1965
Mr. Thomas T. HigginsSr. VP, CFO & Treasurer150kN/A1952
Mr. Michael J. MacDonaldSr. VP of Commercial Operations & GM of DiagnosticsN/AN/AN/A
Dr. Xuan Kong Ph.D.Chief Data ScientistN/AN/AN/A
Ms. Susan M. Bell R.N.Sr. VP of Population Health & Value Based CareN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Japan, China, the Middle East, and Mexico. The company has a strategic collaboration with GlaxoSmithKline. NeuroMetrix, Inc. was founded in 1996 and is based in Woburn, Massachusetts.

Corporate governance

NeuroMetrix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.